Skip to main content Skip to main navigation menu Skip to site footer

Sindrom metabolik merupakan faktor risiko terjadinya psoriasis

Abstract

Pendahuluan: Psoriasis merupakan penyakit kulit in amasi kronis yang dicirikan oleh lesi berupa papul dan plak eritema dengan skuama tebal, kasar, kering serta berwarna putih keperakan. Penyakit dengan prevalensi bervariasi dari 1% sampai 3% di dunia ini umumnya dijumpai pada area predisposisi seperti kulit kepala, ekstensor, bokong, tangan, kaki, serta genitalia. Penderita psoriasis sering kali mengalami penyakit komorbid lain seperti sindrom metabolik, penyakit kardiovaskular, artritis rematoid, penyakit Crohn, kolitis ulserativa, limfoma Hodgkin, limfoma sel-T kutis dan berbagai kelainan psikologis. Sindrom metabolik dide nisikan sebagai kumpulan faktor risiko kardiometabolik yaitu obesitas sentral, hiperlipidemia, hipertensi, dan resistensi insulin. Penelitian ini bertujuan untuk membuktikan bahwa sindrom metabolik merupakan faktor risiko terjadinya psoriasis.

Bahan dan Metode: Penelitian case-control ini dilakukan di Poliklinik Kulit dan Kelamin RSUP Sanglah Denpasar selama periode 1 November 2016 hingga 1 Januari 2017. Populasi terjangkau adalah semua pasien psoriasis yang berkunjung ke Poliklinik Kulit dan Kelamin RSUP Sanglah Denpasar selama rentang waktu tersebut.

Hasil: Hasil penelitian ini memperoleh bahwa sindrom metabolik meningkatkan risiko terjadinya psoriasis [RO=12,3 (IK95%=3,4 sampai 44,2), P < 0,001], sehingga disimpulkan bahwa sindrom metabolik merupakan faktor risiko psoriasis.

Kesimpulan: Sindrom metabolik merupakan faktor risiko terjadinya psoriasis.

 

Introduction: Psoriasis is a chronic in ammatory skin disease characterized by erythematous papules and plaques covered by white to silvery dry, coarse and thick scales. The disease with prevalence 1-3% around the world is usually found on predisposing areas such as scalp, extensor extremities, hands, feet, and genitalia. Patients with psoriasis often have other comorbid diseases such as metabolic syndrome, cardiovascular disease, rheumatoid arthritis, Crohn disease, ulcerative colitis, Hodgkin lymphoma, cutaneous T-cell lymphoma, and psychological disorders. Metabolic syndrome was de ned as the presence of cardiometabolic risk factors such as central obesity, hyperlipidemia, hypertension, and insulin. This case-control study was conducted to prove if metabolic syndrome is a risk factor of psoriasis. resistance.

Method: This case-control study is conducted in Dermatology Polyclinic of Sanglah General Hospital from 1st November 2016 to 1st January 2017. The target population is all patients visiting the polyclinic during the time period.

Result: The result of this study shows that metabolic syndrome increases the risk of psoriasis [OR=12.3 (95%CI=3.4 to 44.2), P <0.001]. It was concluded that metabolic syndrome is a risk factor of psoriasis.

Conclusion: Metablic syndrome is a risk factor of psoriasis

References

  1. Kartal SP, Altunel CT. Psoriasis and metabolic syndrome. J Turk Acad Dermatol. 2015;9(2):1-26.
  2. Zindanci I, Albayrak O, Kavala M, Kocaturk E, Can B, Sudogan S, dkk. Prevalence of metabolic syndrome in patients with psoriasis. The Scientific World Journal. 2012;10:1-5.
  3. Love TJ, Qureshi AA, Karlson EW, Gelfand JM, Choi HK. Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey 2003–2006. Arch Dermatol. 2011; 147(4):419–424.
  4. Cohen AD, Sherf M, Vidavsky L, Vardy D, Shapiro J, Meyerovitch J. Association between psoriasis and the metabolic syndrome. Dermatology. 2008;216:152-155.
  5. Sales R, Torres T. Psoriasis and metabolic syndrome. Acta Dermatovenerol Croat. 2014; 22(3):169-174.
  6. Leovigildo ES, David RA, Mendes AS. Stress level of people with psoriasis at a public hospital. An Bras Dermatol. 2016;91(4): 446-454.
  7. Davidovici BB, Sattar N, Jo PC, Puig L, Emery P, Barker JN, dkk. Psoriasis and systemic inflammatory diseases: Potential mechanistic links between skin disease and co-morbid conditions. Journal of Investigative Dermato logy. 2010; 130: 1785–1796.
  8. Albareda M, Ravella A, Castello M, Saborit S, Peramiquel L, Vila L. Metabolic syndrome and its components in patients with psoriasis. SpringerPlus. 2014;3: 612-619.
  9. Azfar RS, Gelfand GM. Psoriasis and metabolic disease: Epidemio logy and Pathophysiology. Curr Opin Rheumatol. 2008;20(4):416–422.
  10. Liu Y, Krueger JG, Bowcock, AM. Psoriasis: genetic associations and immune system changes. Genes Immun. 2007; 8(1):1–12.
  11. Gerkowicz A, Pietrzak A, Szepietowski JC, Radej S, Chodorowska G. Biochemical markers of psoriasis as a metabolic disease. Folia Histoche mica et Cytobiologica. 2012; 50(2):155–170.
  12. Gudjonsson JE, Elder JT. Psoriasis. In: Goldsmith LA, Katz, SI, Gilchrest BA, Paller AS, Leffell DJ. dan Wolff K., editors Fitzpatrick’s Dermatology in General Medicine edisi ke 8. New York: McGraw-Hill. 2012. h. 197–231.
  13. Alberti G, Zimmet P. The IDF consensus. International Diabetes Federation. 2006;243(4):1-23.
  14. Wannamethee SG, Lowe GD, Rumley A. Adipokines and risk of type 2 diabetes in older men. Diabetes Care. 2007;30:1200–1205.

How to Cite

Kris, M. V., Adiguna, M. S., & Wardhana, M. (2019). Sindrom metabolik merupakan faktor risiko terjadinya psoriasis. Medicina, 50(2). https://doi.org/10.15562/medicina.v50i2.118

HTML
198

Total
182

Share

Search Panel